In February 2022, the Indian pharmaceutical company Cadila Healthcare had the highest moving annual revenue from its cardia drug formulation Atorva, with an earning of almost 1.9 billion Indian rupees. This was closely followed by the respiratory drug Deriphyllin generating an annual revenue of over 1.8 billion rupees respectively.
Revenue of Cadila Healthcare India in February 2022, by leading therapy drug
(in billion Indian rupees)
Characteristic
Revenue in billion Indian rupees
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Motilal Oswal Group. (March 8, 2022). Revenue of Cadila Healthcare India in February 2022, by leading therapy drug (in billion Indian rupees) [Graph]. In Statista. Retrieved July 27, 2024, from https://www.statista.com/statistics/1096948/india-cadila-healthcare-revenue-by-therapy-drugs/
Motilal Oswal Group. "Revenue of Cadila Healthcare India in February 2022, by leading therapy drug (in billion Indian rupees)." Chart. March 8, 2022. Statista. Accessed July 27, 2024. https://www.statista.com/statistics/1096948/india-cadila-healthcare-revenue-by-therapy-drugs/
Motilal Oswal Group. (2022). Revenue of Cadila Healthcare India in February 2022, by leading therapy drug (in billion Indian rupees). Statista. Statista Inc.. Accessed: July 27, 2024. https://www.statista.com/statistics/1096948/india-cadila-healthcare-revenue-by-therapy-drugs/
Motilal Oswal Group. "Revenue of Cadila Healthcare India in February 2022, by Leading Therapy Drug (in Billion Indian Rupees)." Statista, Statista Inc., 8 Mar 2022, https://www.statista.com/statistics/1096948/india-cadila-healthcare-revenue-by-therapy-drugs/
Motilal Oswal Group, Revenue of Cadila Healthcare India in February 2022, by leading therapy drug (in billion Indian rupees) Statista, https://www.statista.com/statistics/1096948/india-cadila-healthcare-revenue-by-therapy-drugs/ (last visited July 27, 2024)
Revenue of Cadila Healthcare India in February 2022, by leading therapy drug (in billion Indian rupees) [Graph], Motilal Oswal Group, March 8, 2022. [Online]. Available: https://www.statista.com/statistics/1096948/india-cadila-healthcare-revenue-by-therapy-drugs/